Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent

被引：1
|
作者：
Niscola, Pasquale [1 ]
Tendas, Andrea [1 ]
Scaramucci, Laura [1 ]
Giovannini, Marco [1 ]
Fratoni, Stefano [2 ]
de Fabritiis, Paolo [1 ]
机构：
[1] St Eugenio Hosp, Hematol Div, Rome, Italy
[2] St Eugenio Hosp, Pathol Dept, Rome, Italy
来源：
BLOOD RESEARCH | 2015年 / 50卷 / 02期
关键词：
D O I：
10.5045/br.2015.50.2.113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 114
页数：2
相关论文
共 27 条
  • [1] SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    LEUKEMIA RESEARCH, 2015, 39 : S137 - S138
  • [2] SUCCESSFUL RETREATMENT WITH AZACITIDINE OF A PATIENT WITH ACUTE MYELOID LEUKEMIA TRANSFORMED FROM MYELODYSPLASTIC SYNDROME AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Piccioni, D.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    HAEMATOLOGICA, 2015, 100 : 103 - 103
  • [3] OUTCOME OF AZACITIDINE TREATMENT AND INCIDENCE OF FEBRILE EVENTS IN "REAL WORLD" PATIENTS WITH MDS OR LOW-BLAST COUNT AML
    Voso, M. T.
    Niscola, P.
    Piciocchi, A.
    Fianchi, L.
    Maurillo, L.
    Musto, P.
    Pagano, L.
    Mansueto, G.
    Criscuolo, M.
    Aloe-Spiriti, M. A.
    Buccisano, F.
    Venditti, A.
    Tendas, A.
    Piccioni, A. L.
    Zini, G.
    Latagliata, R.
    Filardi, N.
    Fragasso, R.
    Fenu, S.
    Breccia, M.
    LEUKEMIA RESEARCH, 2015, 39 : S99 - S99
  • [4] Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment
    Sebert, Marie
    Bally, Cecile
    Peterlin, Pierre
    Beyne-Rauzy, Odile
    Legros, Laurence
    Gourin, Marie Pierre
    Sanhes, Laurence
    Wattel, Eric
    Gyan, Emmanuel
    Park, Sophie
    Stamatoullas, Aspasia
    Banos, Anne
    Laribi, Kamel
    Jueliger, Simone
    Bevan, Luke
    Chaffaut, Cendrine
    Sapena, Rosa
    Samey, Benedicte
    Chermat, Fatiha
    Chevret, Sylvie
    Ades, Lionel
    Fenaux, Pierre
    BLOOD, 2016, 128 (22)
  • [5] Favorable Outcomes of DDX41-Mutated MDS and Low Blast Count AML Treated with Azacitidine with or without Lenalidomide (ALLG MDS4 Trial)
    Tiong, Ing S.
    Stevenson, William S.
    Wall, Meaghan
    Yap, Yan Zhuang
    Seymour, John F.
    Kenealy, Melita
    Blombery, Piers
    BLOOD, 2022, 140 : 4090 - 4091
  • [6] High Healthcare Utilization and Costs in Patients with Higher-Risk MDS/Low Blast Count AML Treated with Azacitidine in Ontario, Canada
    Mozessohn, Lee
    Cheung, Matthew
    Mittmann, Nicole
    Earle, Craig C.
    Liu, Ning
    Buckstein, Rena
    BLOOD, 2018, 132
  • [7] Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'
    Mozessohn, Lee
    Cheung, Matthew C.
    Mittmann, Nicole
    Earle, Craig C.
    Liu, Ning
    Buckstein, Rena
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1445 - 1454
  • [8] ACUTE MYELOBLASTIC-LEUKEMIA WITH A LOW BLAST COUNT (AML-LBC) IS DISTINCT FROM MYELODYSPLASTIC SYNDROME (MDS)
    HEAD, D
    CHAN, GCF
    WANG, W
    BEHM, F
    RAIMONDI, S
    KRANCE, R
    BUTLER, D
    LABORATORY INVESTIGATION, 1995, 72 (01) : A112 - A112
  • [9] Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
    Prebet, Thomas
    Charbonnier, Aude
    Gelsi-Boyer, Veronique
    Mozziconacci, Marie Joelle
    Blaise, Didier
    Vey, Norbert
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1538 - 1540
  • [10] DISTINCTION OF ACUTE MYELOID-LEUKEMIA (AML) WITH LOW BLAST COUNT FROM PEDIATRIC MYELODYSPLASTIC SYNDROME (MDS) IS CLINICALLY IMPORTANT
    CHAN, GCF
    WANG, W
    RAIMONDI, S
    BEHM, F
    KRANCE, R
    HEAD, D
    BLOOD, 1994, 84 (10) : A315 - A315
123